Please login to the form below

Not currently logged in
Email:
Password:

Cohn & Wolfe's Emma Reynolds wins Communiqué Young Achiever

Judges praise her for being at the cutting edge of healthcare comms

Communique Awards 2017 Young Achiever Emma Reynolds

Cohn & Wolfe’s Emma Reynolds was presented with Communiqué’s Young Achiever in Healthcare Communications award last week in London.

The Communiqué judges said: “We felt Emma was comfortable being at the cutting edge of healthcare communications and that she relished that challenge of where PR will go in the future.

“She gave an interesting, self-reflective presentation that was rich with anecdotes and insightful answers. She stood out for her authenticity and we felt she’s someone who would make a real difference at an agency.”

Reynolds’ was Cohn and Wolfe’s first integrated digital communications expert and her work revolves around digital media and video storytelling techniques to help her clients stand out within the pharmaceutical sector.

She beat out competition for the award from Red Door Unlimited and Search Unlimited’s Ross Taylor - who won a highly commended award, Cogora Group’s Mia Neve, Havas Just’s Beth Timm and Sanofi’s Harry Thurston-Smith.

Run by PMLiVE's publisher the PMGroup, the Communiqué Awards are specifically designed to recognise and commend excellence and best practice in local, European and international healthcare communications.

* See all the results from the 2017 Communiqué Awards

Article by
Gemma Jones

14th July 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics